PIK3CB and neoplasm: Multiplex immunofluorescence staining for pS6S240/244 confirmed successful attenuation of PI3K/mTOR signalling in tumours treated with PI3K/mTOR or PI3K/mTOR + PD‐1 inhibitors (Figure S2C and D).